Tang Capital Management’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.75M | Buy |
2,500,000
+1,400,000
| +127% | +$1.54M | 0.14% | 111 |
|
2025
Q1 | $1.08M | Buy |
+1,100,000
| New | +$1.08M | 0.06% | 149 |
|
2023
Q3 | – | Sell |
-1,787,775
| Closed | -$4.58M | – | 113 |
|
2023
Q2 | $4.58M | Sell |
1,787,775
-693,887
| -28% | -$1.78M | 0.67% | 41 |
|
2023
Q1 | $9.95M | Sell |
2,481,662
-989,038
| -28% | -$3.97M | 1.48% | 22 |
|
2022
Q4 | $4.65M | Buy |
3,470,700
+2,059,131
| +146% | +$2.76M | 0.68% | 37 |
|
2022
Q3 | $2.78M | Buy |
1,411,569
+32,489
| +2% | +$64K | 0.34% | 63 |
|
2022
Q2 | $3.28M | Buy |
+1,379,080
| New | +$3.28M | 0.5% | 38 |
|